The enthusiasm and continued support of our existing investors combined with the significant commitment from this new slate of top tier funds provides validation for our circuitbased discovery platform approach the quality of our clinical assets and the strong capabilities of our team said Christopher Kroeger the companys founder and CEO in a statement